logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Necrobiosis Lipoidica Diabeticorum

    Medications for Necrobiosis Lipoidica Diabeticorum

    FiltersReset Filters
    8 results

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for severe allergic states, dermatoses, endocrine and gastrointestinal disorders, hematologic conditions, certain neoplasms, and respiratory diseases. It also treats nervous system issues, renal problems, and rheumatic diseases. Additionally, it can be administered intra-articularly for arthritis and intralesionally for specific dermatologic conditions.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for various conditions, including severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and certain rheumatic diseases. It is also used for cerebral edema, palliative care in neoplastic diseases, and localized therapies in dermatologic conditions via intralesional or intra-articular administration.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Fresenius Kabi USA, LLC
      Usage: This drug is indicated for various conditions requiring intravenous or intramuscular administration, including endocrine disorders, rheumatic diseases, dermatologic issues, severe allergic reactions, and certain gastrointestinal and respiratory diseases. It also addresses hematologic, neoplastic, and neurologic disorders, as well as promoting healing in soft tissue and joint conditions.

    • dexamethasone sodium phosphate

      (DEXAMETHASONE SODIUM PHOSPHATE)
      Fresenius Kabi USA, LLC
      Usage: The drug is indicated for conditions requiring intravenous, intramuscular, intra-articular, or intralesional administration. It treats endocrine disorders, rheumatic and collagen diseases, severe allergic states, dermatologic issues, various gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and certain nervous system conditions.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Hikma Pharmaceuticals USA Inc.
      Usage: This drug is indicated for intravenous or intramuscular use in various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, skin diseases, and gastrointestinal issues. It also addresses respiratory, hematologic, neoplastic, and nervous system disorders, with specific applications for intra-articular, soft tissue, and intralesional administration.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, and intralesional administration to treat severe allergic reactions, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, neurological, ophthalmic, renal, respiratory, and rheumatic disorders, as well as specific inflammatory conditions and acute exacerbations.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, and intralesional use to manage severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, neoplastic diseases, nervous system conditions, and various rheumatic and ophthalmic disorders.

    • methylprednisolone acetate

      (Methylprednisolone Acetate)
      Eugia US LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular use in severe allergies, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, and rheumatic disorders. It is also used for intra-articular or soft tissue administration for specific joint conditions and intralesional administration for various localized dermatologic issues.